170613 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.); Acyltransferases (2.3); Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
Sub-classes:THERAPEUTIC AGENT FOR TREATING HIF-1alpha-MEDIATED DISEASES BY INHIBITING AREL1 AND RESTORING PHD2 ACTIVITY
#2DCIS RECURRENCE AND INVASIVE BREAST CANCER
#3HIGH-THROUGHPUT SCREENING METHODS TO IDENTIFY SMALL MOLECULE TARGETS
#4ASSESSMENT OF CHRONIC LIVER DISEASE
#5METHOD OF PROGNOSIS AND FOLLOW UP OF PRIMARY LIVER CANCER
#6Methods and monitoring of treatment with lanifibranor
#7METHODS OF DETERMINING A HEALTH STATUS OF A CAT BASED ON ONE OR MORE BIOMARKERS, AND METHODS OF TREATING A MORTALITY RISK IDENTIFIED BY THE HEALTH STATUS
#8METHOD FOR IDENTIFYING LIVER FIBROSIS
#9RENAL CELL POPULATIONS AND USES THEREOF
#10BACTERIAL SYSTEMS FOR ANALYZING UBIQUITYLATED POLYPEPTIDES
#11A BLOOD PROFILE ANALYSIS METHOD FOR IDENTIFICATION OF NEW DIABETES DIAGNOSTIC MARKERS IN SARS-COV-2 INFECTED PATIENTS
#12APPLICATION OF NEONATAL BILIARY ATRESIA BIOMARKER AND DETECTION METHOD FOR SAME
#13BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS
#14MICROFLUIDIC PLATFORM FOR DETECTION OF LIVER INJURY
#15METHODS FOR THE IDENTIFICATION OF DEGRONS
#16Methods and compositions for determining the functional activity of DNA double strand break repair pathway molecules for assessing germline risk of cancer
#17DCIS RECURRENCE AND INVASIVE BREAST CANCER
#18High-throughput screening methods to identify small molecule targets
#19High-Throughput Screening Methods to Identify Small Molecule Targets
#20RENAL CELL POPULATIONS AND USES THEREOF
#21SELECTIVE DEGRADATION OF PROTEINS
#22ACTIVITY BASED PROBES
#23Method of selection for treatment of subjects at risk of invasive breast cancer
#24Combination of Markers for Predicting the Response to Vx-001
#25METHOD OF SCREENING FOR PEPTIDES CAPABLE OF BINDING TO A UBIQUITIN PROTEIN LIGASE (E3)
#26METHOD OF SELECTION FOR TREATMENT OF SUBJECTS AT RISK OF INVASIVE BREAST CANCER
#27POLYPEPTIDE DIRECTED AGAINST PROTEIN TYROSINE PHOSPHATASE 4A PROTEINS, AND COMPOSITIONS AND METHODS FOR USE THEREOF
#28SYSTEMS AND METHOD FOR SCREENING SMALL MOLECULES OF INTEREST
#29BACTERIAL SYSTEMS FOR ANALYZING UBIQUITYLATED POLYPEPTIDES
#30METHOD OF PROGNOSIS AND FOLLOW UP OF PRIMARY LIVER CANCER
#31Biomarkers for graft-versus-host disease
#32Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity
#33Ligase Screening Assay
#34SPECIFIC BIOMARKER SET FOR NON-INVASIVE DIAGNOSIS OF LIVER CANCER
#35Methods and compositions for assessing germline risk of cancer
#36Cysteine labelling
#37Renal cell populations and uses thereof
#38Methods for assessing treatment with a gastrointestinal implant
#39Use of Rad18 inhibitors in the treatment of tumors
#40Bacterial systems for analyzing ubiquitylated polypeptides
#41Sample test method, microfluidic device, and test device
#42METHODS OF DIAGNOSING AND TREATING ABIRATERONE ACETATE- GLUCOCORTICOID -RESISTANT OR -SENSITIVE METASTATIC CASTRATION RESISTANT PROSTATE CANCER
#43DIAGNOSTIC AND THERAPEUTIC EPITOPE, AND TRANSGENIC PLANT
#44USE OF RAD18 INHIBITORS IN THE TREATMENT OF TUMORS
#45Adenylation Enzyme Inhibitors
#46Methods and compositions for assessing germline risk of cancer
#47METHODS FOR PREDICTING THE RISK OF DEVELOPING BREAST CANCER
#48Renal cell populations and uses thereof
#49COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
#50Cysteine labelling
#51BARD1 isoforms in lung and colorectal cancer and use thereof
#52PATHWAY CHARACTERIZATION OF CELLS
#53Specific biomarker set for non-invasive diagnosis of liver cancer
#54GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#55Sample test method, microfluidic device, and test device
#56GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#57RENAL CELL POPULATIONS AND USES THEREOF
#58Kidney disease biomarker
#59TRANSGENIC MOUSE EXPRESSING HUMAN ISOGLUTAMINYL CYCLOTRANSFERASE
#60Methods for detecting live pathogens
#61IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
#62METHODS AND REAGENTS FOR DETECTING SUSCEPTIBILITY TO GRAFT VERSUS HOST DISEASE OR TRANSPLANT RELATED MORTALITY
#63Diagnostic and therapeutic epitope, and transgenic plant
#64Biomarkers for prostate cancer
#65FERRIC REDUCTASE ACTIVITY OF HISTOPLASMA CAPSULATUM Y-GLUTAMYLTRANSFERASE
#66GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#67IMMUNOCHROMATOGRAPHY DEVICE FOR THE DIAGNOSIS OF DISEASES IN A SAMPLE
#68Process for determining S-nitrosothiols in biological fluids
#69Diagnostic And Therapeutic Epitope, And Transgenic Plant
#70Crystal structure of soluble glutaminyl cyclase
#71Diagnostic and therapeutic epitope, and transgenic plant
#72Method for Detecting Anti-Transglutaminase Antibodies
#73Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortality
#74Crystal structure of soluble glutaminyl cyclase
#75Method of diagnosing periodontitis by determining γ-glutamyltranspeptidase
#76Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies
#77FXIII detection for verifying serum sample and sample size and for detecting dilution
#78FXIII detection for verifying serum sample and sample size and for detecting dilution
#79Selective degradation of proteins